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Abstract
Background: Cardiac cryoablation is a minimally invasive procedure to treat cardiac
arrhythmias by cooling cardiac tissues responsible for the cardiac arrhythmia to
freezing temperatures. Although cardiac cryoablation offers a gentler treatment than
radiofrequency ablation, longer interventions and higher recurrence rates reduce the
clinical acceptance of this technique. Computer models of ablation scenarios allow for
a closer examination of temperature distributions in the myocardium and evaluation of
specific effects of applied freeze-thaw protocols in a controlled environment.
Methods: In this work multiple intervention scenarios with two freeze-thaw cycles
were simulated with varying durations and starting times of the interim thawing phase
using a finite element model verified by in-vivo measurements and data from literature.
To evaluate the effects of different protocols, transmural temperature distributions and
iceball dimensions were compared over time. Cryoadhesion durations of the applicator
were estimated in the interim thawing phase with varying thawing phase starting times.
In addition, the increase of cooling rates was compared between the freezing phases,
and the thawing rates of interim thawing phases were analyzed over transmural depth.
Results: It could be shown that the increase of cooling rate, the regions undergoing
additional phase changes and depths of selected temperatures depend on the chosen
ablation protocol. Only small differences of the estimated cryoadhesion duration were
found for ablation scenarios with interim thawing phase start after 90 s freezing.
Conclusions: By the presented model a quantification of effects responsible for cell
death is possible, allowing for the analysis and optimization of cryoablation scenarios
which contribute to a higher clinical acceptance of cardiac cryoablation.
Keywords: Cardiac cryoablation, Modeling and simulation, Ablation scenarios,
Freeze-thaw cycles, Transmural temperature distribution, Cooling rates, Thawing rates,
Cryoadhesion
Background
Cardiac cryoablation (CCA) is a minimally invasive therapeutic procedure using cry-
ocatheters to treat cardiac arrhythmias by cooling cardiac tissues responsible for the
cardiac arrhythmia to freezing temperatures. Compared to the alternative radiofrequency
ablation (RFA), in which the target tissue is heated, the use of refrigerant offers some
advantages, e.g. less endothelial disruption and the capability of the applicator to remain
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at the target location during the ablation due to cryoadhesion [1-3]. Compared to RFA,
longer intervention durations and higher recurrence rates were reported for CCA [2,4,5].
In order to improve applied cryoablation protocols and, consequently, the outcome of
CCA, a better knowledge about the temperature progress in the treated myocardium dur-
ing the procedure is necessary. Multiple studies are available investigating the effects and
temperature distributions/profiles during CCA in-vivo (a list of in-vivo studies can be
found in [6]), in-vitro (e.g. [7,8]) and in-silico [9-11].
In-vivo and in-vitro studies showed that cardiac tissue is sensitive to freezing injury
[6,8,12].Weimar et al. [8] used -20°C as lethal boundary for myocardial cells in their study,
which is a relatively warm lethal temperature compared to other types of tissue (e.g. -50°C
is proposed as lethal temperature for tumor cells [6]). A lethal temperature range between
-10°C and -25°C was also confirmed when applied for longer durations [3,6]. Additional
parameters for acute and delayed cell deathwere identified. A detailed description of abla-
tion parameters, such as cooling rate, tissue temperature, duration of freezing, thawing
rate, the repetition of the freeze-thaw cycle and the interval between freeze-thaw cycles
can be found in [6] and [12].
A reason for the enhanced cell death by repeated freeze-thaw cycles is the cooling rate
increase at the beginning of the second freezing phase [6] caused by precooled surround-
ing tissue and a reduced heat contribution of tissue ablated during the first freeze-thaw
cycle. This cooling rate enhancement consequently leads to more extensive intracellu-
lar ice crystallization, which is one of the main indicators for acute cell death caused by
disruption of cell membranes and organelles [13].
Another factor increasing cell death by multiple freeze-thaw cycles is ice recrystal-
lization and increased solute effects primarily caused by slow thawing rates over longer
durations. For longer thawing phases microcirculation fails and the heat contribution in
this area lessens, which allows for a more effective second freezing phase [6].
The ablation parameters of (multiple) freeze-thaw cycles are strongly dependent
on the distance of the tissue to the applicator: During the first freezing phase
cell death caused by intracellular ice crystallization mainly occurs in areas close
to the applicator, while cell death by solute effects is primarily seen in areas far-
ther away from the cryoprobe [12]. Multiple freeze-thaw cycles can be used to
extend these effects into areas more distant from the cryoprobe [6,12]. To ana-
lyze the aforementioned effects in the myocardial tissue during different cryoabla-
tion scenarios, a detailed examination of the temperature distribution over time is
necessary.
Wood et al. compared lesion dimensions and measured tissue temperatures during
cryoablation in-vitro using tip applicators with different dimensions, applicator orienta-
tions, contact pressures and the presence/absence of superfusate flow [7]. The analysis of
lesion dimensions showed that all described factors have an influence on the final ablation
outcome. The effects leading to an increase of lesion dimensions during the performed
single freeze-thaw cycle (i.e. higher cooling rates and lower minimal temperatures) are
also reflected by the recorded temperature profiles in the myocardium.
Proper mathematical models allow for analyzing temperature distributions during
cryoablation procedures without biases introduced by anatomical variations or the exper-
imental setup. In a work of Chua and Chou, a computer model was created to study the
thermal processes during cryoablation in porcine liver tissue [14]. In the simulations of
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this study, the impact of different thawing durations, thawing temperatures and num-
ber of freeze-thaw cycles on the ablated tissue was compared in terms of calculated ice
volumes and cell survival signatures based on varying cooling and thawing rates. The
study showed that longer thawing periods, passive thawing and the repetition of freeze-
thaw cycles positively affect the ablation outcome. The simulations demonstrated that the
ablation effect on the tissue also depends on the distance to the cryoapplicator surface.
Only a few studies exist focusing on the simulation of temperature distributions/profiles
and corresponding effects on lesion dimensions for cardiac cryoablation. In a previous
study by Seger et al. myocardial temperature distributions were simulated for differ-
ent freezing outlet configurations in a loop shaped cryocatheter [9]. In this study lesion
dimensions were estimated based on the simulated ice formation after 300 s freezing.
It was found that the configuration of the freezing outlets significantly influences the
transmural temperature distribution and, consequently, the lesion characteristics. Find-
ings obtained by these simulations could be confirmed by morphological and histological
examinations.
Recently a computer model based on Pennes’ bioheat equation [15,16] was developed
by our group simulating the temperature distribution in a myocardial tissue layer with 6
mm thickness and a blood layer in contact with the applicator and the endocardium [10].
This model takes into account the different phases of the refrigerant flow in the applicator
in order to consider these effects in the temperature distribution of the simulated tissue
layer. Ice formation (phase change from liquid to solid) influences the thermal proper-
ties of the tissue (specific heat capacity, latent heat, thermal conductivity, metabolic heat
generation and blood perfusion) and the blood layer (material properties as described for
tissue withoutmetabolic heat generation), and was integrated into the model by the effec-
tive heat capacity model [16]. The model was verified by in-vivo measurements at the
applicator tip and lesion dimensions from literature. Therefore it constitutes a good basis
for the investigation of transmural temperature profiles and distributions during different
freeze-thaw scenarios, which is the main focus of this work.
In this work effects on transmural temperature distributions, temperature profiles and
ice dimensions of different thawing durations and thawing start times were analyzed using
a slightly adapted variant of our previously presented model [10]. Characteristic param-
eters of the different phases were quantified over transmural depth and evaluated for
various ablation scenarios. Furthermore, the temperatures at the applicator surface being
in direct contact with the endocardium were selected during the thawing phases to esti-
mate the length of time until the applicator loses cryoadhesion and disengages from the
target ablation area.
Methods
Model
To simulate the temperature distribution in the myocardial tissue and the components
of the ablation system, a true to scale model of a 9 Fr 8 mm applicator (Freezor MAX,
Medtronic Inc., Minneapolis, MN) applied to myocardial tissue with 6 mm transmu-
ral thickness was used, a slightly modified variant of the model presented in [10] (see
Figure 1). The segment of the tip applicator not attached to the endocardium is sur-
rounded by a 3 mm blood layer to simulate the blood stream by highly perfused elements
[10]. A thicker blood layer was simulated in this study allowing to consider temperatures
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Figure 1 Model used for the simulation of temperature fields. Segment of model used for the simulation
of temperature fields during CCA similar to the model presented in [10]. (a) Cross section of applicator’s short
axis. (b) Cross section of applicator’s long axis. (c) FEMmeshing and geometry dimensions.
more distant from the applicator. Additionally, the tissue area in contact with the applica-
tor was reduced to conform to applicator contact areas from literature [17]. The described
model was prepared with the software HyperWorks 12 (Altair Eng. Inc.) and simulated
using the Finite Element Method (FEM). The meshed geometry comprises of 39160 ver-
tices and 214526 tetrahedrons. As temporal differencing scheme the Crank-Nicolson
method [18] was used with a temporal resolution of 10 ms.
To estimate the temperature distribution in living myocardial tissue during the simu-
lated ablation protocols Pennes’ bioheat equation was used [10,15,16]:
ρC(X,T)∂T(X, t)
∂t = ∇ · λ(X,T)∇T(X, t) + Qp(X,T) + Qm(X,T), X ∈  (1)
ρ, C and λ are the material and temperature dependent density (kg m−3), specific heat
capacity (J kg−1 °C−1) and thermal conductivity (W m−1 °C−1) at location X, time t (s)
and temperature T (°C) in the modeled spatial domain . To model the thermal load of
blood perfusion and metabolic heat generation a blood perfusion termQp (Wm−3) and a
metabolic heat contribution termQm (Wm−3) were integrated into themodel. The fusion
enthalpy of freezing blood and tissue was applied proportionally to the phase transition
range between -10°C and 0°C (effective heat capacity model [16]) [10,19].
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To incorporate the heat contribution of adjacent regions in Figure 1 (boundaries a,
b and c) Cauchy boundary conditions were applied. The cooling flux of the refriger-
ant (boundaries d, e and f ) was modeled by time and temperature dependent Neumann
boundary conditions and Cauchy boundary conditions to incorporate different phases of
the refrigerant during a freeze-thaw cycle.
For a detailed description of the perfusion term and metabolic heat contribution term,
distinct material properties and applied boundary conditions used in the model, we refer
to [10]. Due to the experimental model validation carried out in our previous work [10],
the boundary condition of the epicardial surface c was set to approximate open chest
conditions. For this study we slightly adapted this boundary condition to the closed chest
situation using the values of Seger et al. [9] by increasing the heat transfer coefficient
α to 200 W m−2 °C−1 and the external temperature Tc to body temperature (36.5°C).
The simulated temperature fields were compared with our previous model [10] showing
a similar characteristic at the applicator tip. However, reduced ice volumes in the tissue
were detected, which are primarily caused by the increased heat transfer coefficient at the
epicardial boundary.
Ablation scenario evaluation
To investigate the relevant ablation measures (minimal temperatures, cooling and thaw-
ing rates, progress of phase change boundaries) of different scenarios with two freeze-
thaw cycles, transmural temperature profiles were computed between the coolest point at
the epicardium and the applicator, and selected isotherms were extracted (see schematic
overview of transmural temperature profiles in Figure 2). Furthermore, the ice vol-
ume (tissue below solidus temperature of -10°C) was calculated and compared between
different protocols.
To evaluate the influence on cooling rates in different transmural depths average cooling
rates were calculated based on transmural temperature profiles. The average cooling rate
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Figure 2 Isotherms of schematic transmural temperature depths over time. Isotherms of schematic
transmural temperature depths over time for a cryoablation scenario with two freeze-thaw cycles (150 s
freezing followed by 10 s thawing, 150 s freezing and rewarming).
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CRi (°C s−1) of freezing phase i (first freeze i = 1, second freeze i = 2) was calculated
by
CRi = TcomptiF(Tcomp) , (2)
where the temperature interval Tcomp (°C) (dark gray temperature range in Figure 3) is
a central part of the temperature range during the first thawing phase Trise (°C) (light
gray temperature range in Figure 3). Trise is defined as the temperature interval between
the minimal temperature during the first freezing phase (min(T1F) (°C) in Figure 3) and
the maximal temperature during the interim thawing phase (max(T1T) (°C) in Figure 3).
Due to the slow temperature reduction at the beginning of the second freezing phase
(see temperature curve progression right after max(T1T) in Figure 3), only the central
temperature range covering 60% of Trise was used for the cooling rate computation of the
first and second freezing phase in this study. tiF(Tcomp) (s) defines the time needed to pass
the temperature interval Tcomp in freezing phase i.
The thawing rate for the simulated protocols was calculated correspondingly using
the time range t1T(Tcomp) needed to pass Tcomp in the interim thawing phase in the
denominator of Equation 2.
Simulated ablation scenarios
One of the main factors influencing the lesion dimension and destruction rate in multi-
ple freeze-thaw cycles is the thawing phase between two freezing phases. In a first step
the cryoadhesion duration of the applicator was analyzed during the thawing phase after
previous freezing phases with different durations (see schematic ablation scenarios A1-
A3 in Figure 4). To specifically investigate the effect of different thawing scenarios with
two freeze-thaw cycles the accumulated freezing time was set to 300 s and the thawing
duration and thawing start (initial freezing duration) were altered in the simulations (see
schematic ablation scenarios B-D in Figure 4).
The duration of thawing between two consecutive freezing phases is one of the main
factors affecting the efficiency of multiple freeze-thaw cycles. While longer thawing peri-
ods lead to increased efficacy due to recrystallization and osmotic damage [6,12], the
Figure 3 Temperature and time values/ranges used for comparable cooling/thawing rate
computation. Schematic temperature profile in myocardium with characteristic temperature values, and
temperature and time ranges for the calculation of comparable cooling rates for the first and second freezing
phase (CR1, CR2) and thawing rates for the interim thawing phase (TR1). Trise is the temperature range during
the first thawing phase, min(T1F) and min(T2F) define the minimal temperatures of the first and second
freezing phase, respectively, max(T1T) is the maximal temperature during the interim thawing phase, and
t1F(Tcomp), t2F(Tcomp) and t1T(Tcomp) are the durations needed to pass the comparative temperature range
Tcomp in the first and second freezing phase and the interim thawing phase, respectively.
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D
Figure 4 Schematic overview of simulated ablation scenarios. A: Cryoadhesion analysis during thawing
phases after initial freezing phase durations of 90 s (A1), 150 s (A2) and 210 s (A3). B: Single freeze-thaw cycle
with 300 s freezing and final rewarming (B1). C: Alteration of interim thawing phase duration (C1: 5 s, C2: 10 s,
C3: 15 s, C4: 20 s) after 150 s freezing followed by a second freezing phase of 150 s. D: Alteration of initial
freezing phase duration (D1: 90 s, D2: 150 s, D3: 210 s) followed by an interim thawing phase of 10 s in
scenarios with two freeze-thaw cycles with a cumulated freezing duration of 300 s.
adhesion of the applicator to the treatedmyocardium is negatively affected through longer
thawing phases. The applicator remains attached to the endocardium by ice formation
around the applicator until the tissue region in contact with the applicator undergoes
phase transition from solid to liquid. To evaluate the thawing duration with preserved
adhesion, the average temperature of the endocardial surface in contact with the appli-
cator tip was analyzed in the thawing phase after initial freezing of 90 s, 150 s and
210 s. Once the average temperature of the endocardial tissue reaches the solid phase
transition temperature of -10°C the applicator starts to disengage from the myocardial
tissue. It should be noted that this does not imply an immediate loss of adhesion of the
applicator after this short thawing period. The phase change from solid to liquid is not
completed until the previously subtracted latent heat is added to the tissue again. The tar-
get temperature of -10°C was chosen to consider the “worst case” in our analysis. In our
simulations the duration of the interim thawing phase after 150 s freezing was varied in
a small range around the estimated minimal thawing time with persisting cryoadhesion.
Based on the simulation results transmural temperature profiles were extracted to analyze
effects, which influence the ablation outcome.
The tissue volume affected by repeated freezing is influenced in a high degree by
the duration of the first freezing phase due to recrystallization of ice crystals devel-
oped during the initial freezing of tissue. To analyze temperature profiles of involved
tissue regions for variable lengths of initial freezing phases, the first thawing phase
of 10 s was started between 90 s and 210 s after the beginning of the first freezing
phase. The duration of the second freezing phase corresponds to the time remain-
ing to 300 s freezing. Analogous to the measurements for different thawing durations
transmural temperature profiles, ice volumes and the increase of cooling rates were
extracted over time and compared for different starting times of the interim thawing
phase.
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Results
To compare the influence of different freeze-thaw cycle variants on the ablated
myocardial tissue, cryoadhesion durations were estimated, and transmural temperatures
and ice volumes (myocardial tissue volume with temperatures lower than the solidus
temperature of -10°C) were extracted from the simulated temperature fields. In addi-
tion, cooling and thawing rates between the succeeding freezing phases of the simulated
variants were compared.
Cryoadhesion analysis
To estimate the thawing duration without losing the effect of cryoadhesion a deactivation
of the applicator was simulated after 90 s, 150 s and 210 s of freezing and the time was
measured until the contact area between applicator and myocardium reaches an average
temperature of -10°C. Mainly due to the heating effect of the surrounding blood stream
this temperature boundary is already reached after approximately 12 s (11.7 s) thawing
in the scenario with 150 s initial freezing phase (scenario A2 in Figure 4). After this time
the contact area between applicator and tissue reaches the lower boundary of the phase
change temperature range in the simulation. The liquid phase change boundary of 0°C
is reached at the surface between applicator and tissue after deactivating the applicator
for approximately 40 s (41.5 s). The thawing duration until the applicator surface in con-
tact with the tissue reaches the lower phase change boundary is similar compared to the
investigated protocols with differing thawing starting times. When the applicator is deac-
tivated after 90 s freezing (scenario A1 in Figure 4), the boundary between the applicator
and the myocardial tissue reaches an average temperature of -10°C after 11 s and an aver-
age temperature of 0°C after 40.2 s. For the longer initial freezing phase of 210 s (scenario
A3 in Figure 4) the thawing duration increases slightly to 12 s until a mean temperature
of -10°C is reached at the applicator/tissue boundary. After 41.9 s the boundary between
applicator and tissue warms up to 0°C.
Single freeze-thaw cycle
To obtain a reference of transmural temperature distribution and ice volume growth over
time a single freeze-thaw cycle of 300 s freezing followed by rewarming was simulated
(scenario B1 in Figure 4). Figure 5 depicts the temperature distribution at the end of the
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Figure 5 Simulated temperature distribution after 300 s freezing. Black isotherms denote 10°C steps.
0°C, -10°C and -20°C isotherms are highlighted in white, cyan and green, respectively. Crosses at -10°C and
-20°C isotherms depict the maximal depth of the corresponding isotherm.
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freezing phase. After 300 s freezing, the frozen volume reaches a transmural depth of 4.5
mm relative to the applicator surface, and the myocardium within a transmural distance
of 3.2 mm is frozen below the necrotic temperature of -20°C (see Figure 6a and Table 1).
The transmural extent of the iceball is comparable with lesion depths measured in an in-
vivo study of Khairy et al. [20] (4.8 ± 2.7 mm) using a 9 Fr 8 mm applicator for CCA
in adult miniature swine. Tse et al. [17] obtained similar lesion depths in a thigh muscle
preparation to simulate intracardiac conditions during cryoablation using a 10 Fr 6.5 mm
tip applicator with similar tissue contact area (4.9 ± 1.5 mm).
Amaximal frozen volume of 333mm3 is reached at the end of the freezing phase, which
is the simulated maximum iceball volume for all simulated scenarios (see Figure 6b and
Table 1).
Thawing duration
Figure 6 shows the transmural temperature and ice volume progress for different thaw-
ing durations after an initial freezing phase of 150 s (scenarios C1-C4 in Figure 4). In
Figure 6a, isotherms of the transmural temperature distribution over time are plotted
for the protocols without interim thawing phase and interim thawing phases of 5 s and
10 s after 150 s initial freezing, followed by a second freezing phase of 150 s and final
rewarming. While tissue within 2.3 mm of transmural distance reaches the necrotic
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Figure 6 Isotherms of transmural temperatures and ice volumes for varying interim thawing phase
durations. Isotherms of transmural temperatures (a) and ice volumes (b) over time for ablation protocols
with 150 s initial freezing phase, interim thawing phases with varying duration, 150 s second freezing phase
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Table 1 Transmural isotherm depths and ice volumes for varying interim thawing phase
durations
Thaw dur. 1F 1T 2F
(s) -10°C -20°C IV -10°C -20°C IV -10°C -20°C IV
(mm) (mm) (mm3) (mm) (mm) (mm3) (mm) (mm) (mm3)
0 X X X X X X 4.5 3.2 333
5 4.1 3.0 286 3.3 0.6 170 4.4 3.2 326
10
...
...
... 2.5 0.0 94 4.4 3.2 322
15
...
...
... 0.0 0.0 0 4.4 3.2 319
20 4.1 3.0 286 0.0 0.0 0 4.4 3.2 316
Transmural depths of selected isotherms and ice (= tissue below solidus temperature of -10°C) volumes (IV) for ablation
protocols with an initial freezing phase of 150 s, an interim thawing duration between 0 s and 20 s, a second freezing phase
of 150 s and final rewarming.
temperature of -20°C within the first minute of freezing, the myocardium more distant
from the applicator shows a comparably slow decrease of temperature indicated by the
slow increase of isotherms. The transmural extent of the iceball after 150 s simulation
(4.1 mm) is comparable with lesion depths described in the study of Tse et al. [17] after
150 s freezing (3.8 ± 1.0 mm). Once the first freezing period ends after 150 s, the dis-
tances of the depicted isotherms to the applicator reduce rapidly due to the strong thermal
load of the blood stream. In contrast, only a marginal reduction of the 0°C isotherm can
be seen. The slow rewarming of areas with temperatures above the solidus temperature
(-10°C) is caused by the latent heat required for the phase change, which must be added
to the tissue again before a further rise in temperature is possible. During the rewarm-
ing of tissue an increase of solute effects and recrystallization of previously developed
ice crystals takes place. The impact of these effects is stronger the longer the thawing
duration lasts [6,12]. Additionally, the transmural zone entering the temperature range
for phase transition from solid to fluid (-10°C to 0°C) during the thawing phase is signif-
icantly greater at longer thawing phases (see -10°C isotherm depth and ice volume after
first freezing and first thawing phase in Table 1). After the thawing period the second
freezing phase is started, leading to an immediate drop of temperatures especially in the
fully frozen volume. The depicted isotherms reach approximately the same depth at the
end of the second freezing phase (see also Table 1). As shown in a work of Chua and Chou
[14], the simulated volume being thawed during the first thawing phase and refrozen dur-
ing the second freezing phase showed significantly lower viability compared to scenarios
with shorter thawing periods, in which the corresponding volume remained in the frozen
state. This can be explained by the increased influence of thawing effects during longer
thawing periods and the repetition of the effects induced by freezing. During the interim
thawing period with 5 s duration the phase change boundary of -10°C does not recede to
the depth of the necrotic -20°C isoline reached during the first freezing phase, indicating
a higher chance of cell survival in the myocardial range between 3 mm and 3.5 mm trans-
mural depth (see Figure 6a). In the simulation with 10 s rewarming the isoline recedes to
a distance closer to the applicator than the -20°C isoline in the first freezing phase, closing
this gap and increasing the chance of lower viability in this transmural range.
Figure 6b depicts the ice (solidus temperature isotherm) volume progress over time in
the myocardium showing similar characteristics. In the ablation protocols with 15 s and
20 s interim thawing duration, the whole ice volume created during the first freezing
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phase enters the temperature range of phase change again and is refrozen during the sec-
ond freezing cycle. Despite the significant differences in the minimal volume during the
first thawing phase, approximately equal ice volumes are reached at the end of the second
freezing phase for all simulated protocols.
In Figure 7, the results of the cooling rate comparison between the first and sec-
ond freezing phases are summarized for different scenarios over the transmural depth.
Figure 8 depicts the common temperature ranges of both freezing phases and thaw-
ing rates for different thawing phase durations and starting times. Higher temperature
changes and thawing rates can be observed closer to the endocardium due to the more
direct impact of the applicator and the fast rewarming of the tissue by the nearby blood
stream. At farther distances the respective temperature ranges are reduced implying a
smaller influence of the interim thawing phase. Due to the common start of the interim
thawing phase, the lower boundary of the common temperature range is equal for the
protocols with varying thawing durations. For the protocol with 5 s interim thawing phase
the maximal thawing temperature close to the applicator is significantly lower compared
to longer thawing durations. At longer thawing durations the tissue reaches temperatures
close to -10°C. Only small variations of the maximum interim thawing temperature are
visible for these protocols due to the latent heat considered by the effective heat capacity
model in the phase change temperature range between -10°C and 0°C.
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Figure 7 Comparison of averaged cooling rates over transmural depth. (a) Cooling rates of first (CR1)
and second freezing phase (CR2). (b) Cooling rate increase in second freezing phase.
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Figure 8 Temperature ranges and thawing rates of the interim thawing phase. Temperature ranges (a)
and thawing rates (b) of the interim thawing phase over transmural depths for simulated ablation protocols.
In (a)min(T1F) marks the lines of the minimum temperatures during the first freezing phase and max(T1T)
marks the maximum temperatures during the interim thawing phase. The green line starting at -82.6°C
defines the minimal temperature of the first freezing phase of all protocols with an initial freezing phase
duration of 150 s.
For shorter thawing durations the increase of the cooling rate depicted in Figure 7b is
higher compared to longer thawing durations, especially at distances close to the applica-
tor. More myocardial volume undergoes phase change again at longer thawing durations
leading to a higher heat capacity at the beginning of the second freezing phase by latent
heat resulting in lower cooling rates compared to shorter interim thawing phases.
The thawing rates depicted in Figure 8b show a similar characteristic. Although the
thawing rates are equal at the beginning of the interim thawing phases after 150 s freezing,
different temperatures are reached when the second freezing phase is started. The highest
thawing rate was calculated for the shortest interim thawing phase of 5 s. During the
short temperature rise in this protocol the lower phase change boundary is not reached.
The crossing of the phase change boundary in simulations with longer thawing durations
leads to a reduced thawing rate in these protocols.
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Initial freezing duration
The volume of myocardial tissue affected by the interim thawing phase depends on the
duration of the initial freezing phase. The duration defines the size of the iceball, in which
the effects of recrystallization take place, and furthermore the extent of the precooling of
surrounding tissue, which affects the cooling rate of the second freezing phase.
Figure 9 shows the isotherms of the transmural temperature profile and ice volume over
time for the ablation protocols with varying starting times of the interim thawing phase
(scenarios D1-D3 in Figure 4). The depth and volume crossing the solidus temperature
of -10°C twice during the first thawing and second freezing phase varies depending on
the start of the first thawing phase. A quantitative summary of transmural depths of the
shown isotherms and the ice volume is given in Table 2. Beyond longer initial freezing
phases the recrystallization and osmotic effects of the interim thawing phase are extended
to areas more distant from the applicator and, consequently, a greater volume is affected.
Variations in the starting time of the interim thawing phase have a minimal influence
on the depths of the -10°C and -20°C isotherms after the second freezing phase. A later
start of the interim thawing phase leads to slightly warmer temperatures at the end of the
second freeze, mainly caused by the shorter second freezing cycle. The depicted results of
the ablation protocol starting the interim thawing phase after 210 s also show that the ice
volume of the first freeze is not reached completely after the second freezing phase. Also,
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Figure 9 Isotherms of transmural temperatures and ice volumes for varying initial freezing phase
durations. Isotherms of transmural temperatures (a) and iceball volumes (b) over time for ablation
protocols with 10 s thawing phase starting after different initial freezing durations and a cumulated freezing
duration of 300 s.
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Table 2 Transmural isotherm depths and ice volumes for varying initial freezing phase
durations
Thaw start 1F 1T 2F
(s) -10°C -20°C IV -10°C -20°C IV -10°C -20°C IV
(mm) (mm) (mm3) (mm) (mm) (mm3) (mm) (mm) (mm3)
90 3.6 2.7 230 1.9 0.0 64 4.5 3.2 328
150 4.1 3.0 286 2.5 0.0 95 4.4 3.2 322
210 4.3 3.1 314 2.8 0.0 110 4.3 3.1 310
Transmural depths of selected isotherms and ice (tissue below solidus temperature of -10°C) volumes (IV) for ablation
protocols with varying starting times of interim thawing phase of 10 s and a cumulated freezing duration of 300 s.
a greater volume is rewarmed to temperatures above the lower phase change boundary
and is being refrozen in the second cycle at later starts of the interim thawing phase.
In Figure 7 the cooling rates of the first and second freezing phases are compared
for different starting times of the interim thawing phase. Figure 8a depicts the differ-
ence of the temperature ranges for different thawing phase start times. Warmer minimal
temperatures at the end of the shorter first freezing phase consequently lead to smaller
temperature ranges for rewarming and recooling, especially at farther distances from the
applicator. The varying estimated cooling rates are caused by different precooling con-
ditions of the surrounding tissue as well as by the variations of temperature ranges of
rewarming and refreezing during the interim thawing and second freezing phase. Shorter
initial freezing phases lead to a reduced increase of the cooling rate during the second
freezing phase, especially for farther distances from the applicator. Small enhancements
of the cooling rates are identifiable in protocols with a longer initial freezing phase in
transmural depths of 4 mm, whereas no increase was measured for shorter initial freezing
phases.
Discussion
The treatment of cardiac arrhythmias by cryoablation is gradually gaining more impor-
tance [21] and, therefore, a better understanding of the processes in the treated myocar-
dial tissue is essential to optimize both the procedure itself and the outcome. Although
multiple in-vitro and in-vivo studies are available investigating the effects of CCA (e.g.
[7,17,20,22,23]), only a few studies employ in-silico models for a closer investigation of
temperature distributions over time in the field of CCA, including the studies published
by our group [9-11]. Using in-silico models various procedures can be simulated and
interpreted without shortcomings due to measurement biases induced by the instru-
ments used or by anatomical variations. Additionally, a more detailed investigation of
temperature fields is possible using computer models, allowing the interpretation of
results, which experimentally can, if at all, only be measured with much higher efforts.
Furthermore, ethical aspects have to be considered in in-vivo studies, whereas various
conditions can be tested using in-silico models without the need and danger of harming
subjects.
To analyze transmural temperatures for the evaluation of different ablation procedures
we verified our model using temperature recordings from literature. In a study by Wood
et al. [7] myocardial sections of porcine hearts were ablated using different tip applicators,
among those also a 9 Fr 8 mm tip applicator was used. As the transmural temperature
recordings of ablations using superfusate flow were biased due to conductive warming
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of the array holding the thermal probes as stated by the authors, measurements without
superfusate flow were used for comparison with a slightly modified version of our model
to consider thermally inactive tissue (deactivation of perfusion and metabolic heat con-
tribution) and a steady blood layer above the applicator (deactivation of perfusion in the
blood layer and adaptation of the surrounding boundary conditions). A good approxima-
tion to the measurements of Wood et al. was found (see Appendix), verifying simulations
of our model also in regions more distant from the cryoprobe. However, measuring trans-
mural temperatures during cryoablation in-vivo remains a challenging task. Promising
approaches have been developed for the recording of temperatures in-situ by Thaokar
& Rabin [24] allowing for a more accurate insight into temperature distributions during
thermal ablation procedures.
To investigate only the effects of different modalities concerning multiple freeze-thaw
cycles the overall freezing duration of the simulated ablation procedures compared in this
study was set to 300 s. Longer overall freezing durations were not simulated due to the
quasi-static state of the temperature field at the end of the continuous 300 s freezing phase
(maximal temperature change approximately -0.02°C s−1 after 300 s freezing) implying
only small variations in transmural depth and volume of relevant isotherms. Furthermore,
shorter ablation scenarios lead to a higher clinical acceptance. Nevertheless, it is known
from literature that longer freezing durations enlarge the ablated tissue region, especially
in the temperature range between -10°C and -25°C due to increased solute effects and
recrystallization [3,6].
The analysis of different thawing durations after a freezing phase of 150 s shows that
the temperature distribution within the myocardium is strongly influenced by short
thawing phases of only a few seconds. The fast rewarming of both the tissue and the
applicator can lead to a disengagement from the endocardium and the applicator may
be dislocated in the second freezing phase, if longer thawing durations are chosen. Our
simulations show that already after 90 s freezing the thawing duration until the iced
applicator tip reaches the lower phase change boundary is only marginally dependent
on the initial freezing duration. Although effects of recrystallization and solute effects
are smaller at faster rewarming rates of previously frozen tissue over short periods of
time [6,12,14,25], an interim thawing phase enhances the cooling rate of the second
freeze-thaw cycle, thus increasing the chance of intracellular ice formation. The increase
of the cooling rate depends both on the distance to the applicator and the thermal
history of the tissue. While shorter thawing periods lead to a higher increase of the cool-
ing rate in the second freezing phase compared to longer thawing periods, the higher
cooling rate is only effective in smaller temperature ranges compared to longer thaw-
ing phases. Additionally, longer thawing periods result in a greater volume to undergo
phase change again and being refrozen during the second freezing phase. The thawing
duration should, therefore, be chosen carefully to maximize the range being influenced
by the thawing phase while keeping the applicator adhered to the initial ablation site.
Thawing durations can be prolonged if a close positioning of the applicator to the first
ablation location can be guaranteed, for instance by the usage of specialized navigation
systems.
The region influenced by multiple freeze-thaw cycles also varies according to the dura-
tion of the initial freezing phase. While shorter initial freezing durations cause regions
closer to the applicator to undergo phase change again during the interim thawing phase,
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longer initial freezing phases shift the effect to regions more distal to the applicator. Addi-
tionally, the affected volume is greater when the interim thawing period is started later in
the scenario. This finding indicates that adaptations of the interim thawing phase starting
time are an important factor for the optimization of ablation protocols depending on the
myocardial wall thickness of the relevant ablation site.
Characteristic phases of the refrigerant nitrous oxide (N2O) were considered in the
simulations as previously described in [10]: At the beginning of a freezing phase,
the cooling power of the applicator continuously increases during the filling of the
supply lines and the raise of the refrigerant flow rate. This consequently influences
the cooling rates at the beginning of the freezing phases. At the end of a freez-
ing phase the valve in the supply line is closed. The rewarming of the applicator is
slightly delayed until the remaining refrigerant in the applicator is completely drained.
By considering the characteristic refrigerant phases, a realistic cooling and rewarm-
ing behavior of the applicator and the tissue was simulated for the discussed ablation
scenarios.
In our work, averaged material properties (thermal conductivity, specific heat capac-
ity, blood perfusion rate and metabolic heat generation rate) obtained from literature
were used in combination with a simplified geometrical model [10]. Although temper-
ature distributions are affected by variations of material properties and geometries, the
general trends demonstrated in our simulations remain unchanged. It can be expected
that large blood vessels have an influence on transmural temperature distributions dur-
ing cryoablation and, therefore, on the ablation result. The examination of effects caused
by anatomical variations was not considered in the present model. Our results are based
on averaged conditions and allow for drawing reasonable conclusions on specific ablation
protocols.
Transmural temperature profiles were analyzed between the coldest point at the epi-
cardium after 300 s freezing and the applicator tip, where the transmural extent of relevant
isotherms (phase change boundaries, lethal temperature) is the largest. Along this trans-
mural path, the effects of varying ablation scenarios can be examined best. In addition,
the temperature distribution along this path can also be used for comparison with lesion
depths from literature due to the fact that lesion depths are also measured by the maximal
transmural extent of the lesion.
The presented simulations in this work provide better insight into temperature dis-
tributions over transmural depths during CCA, which may contribute to optimization
strategies depending on the wall thickness of the treated myocardium and furthermore
allow for an improvement of ablation protocols in CCA. In addition to increased abla-
tion success, another improvement is the reduction of intervention time. Obviously,
shorter freezing durations are reasonable for thinner myocardial wall thicknesses as lethal
temperatures reach the epicardium in shorter time spans. By incorporating multiple
freeze-thaw cycles, the ablation time can be decreased by additionally investigating the
volumes undergoing phase change during interim thawing phases and being refrozen in
the following freezing phase.
Conclusions
In summary, we used a powerful simulation model, which was verified by in-vivo exper-
iments confirming the temperature profiles at the applicator, and in-vitro results from
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literature for temperature profiles over transmural depth. This model allows for the anal-
ysis and optimization of established cryoablation scenarios and for the development of
new ablation strategies for future CCA studies. This may contribute to a higher clinical
acceptance for treating cardiac arrhythmias using this technology.
Limitations
Simulated temperature distributions were solely verified by in-vivo temperature measure-
ments at the applicator tip [10] and in-vitro temperature recordings of myocardial tissue
as shown in [7] (see Appendix). In addition, iceball depths (depths of -10°C isotherms)
were compared with lesion depths from literature [17,20].
A quantification of ablated tissue regions (lesion depth, lesion volume) was not possible
due to a lack of experimental data for the simulated ablation protocols. For a comprehen-
sive assessment of protocol parameters (such as interim thawing duration, thawing start
time, and overall ablation duration) on ablation results in CCA, in-vivo experiments with
a sufficient number of ablations are needed and are objectives of future studies.
Appendix
Verification of transmural temperature profiles
In the work of Wood et al. [7], sections of porcine myocardium (20 × 20 × 10 mm)
were ablated using a tip applicator with equal dimensions (9 Fr diameter, 8 mm elec-
trode length) analogously used in our model. Temperature profiles in the myocardium
were recorded using optical temperature probes fixed by a small plastic frame and posi-
tioned 1 mm, 2 mm, 3 mm and 5 mm below the surface in contact with the applicator.
Experiments were performed with and without superfusate flow over the electrode-tissue
interface. The authors state in their study limitations that the array carrying the tempera-
ture probes was exposed to the superfusate and, consequently, the tissue and temperature
probeswerewarmed by the superfusate during the ablation. Therefore, themeasurements
without superfusate flow were used for comparison with an adapted model.
Themodified model contains an inactive tissue layer (Qm = Qp = 0) with equal dimen-
sions (20× 20× 10mm), an inactive blood layer (Qp = 0) of 3 mm thickness and adapted
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Figure 10 Comparison of transmural temperature profiles in-silico vs. in-vitro. Comparison of
transmural temperature profiles obtained from simulation (solid lines) and from Wood et al. [7] (dashed lines)
in 1 mm, 2 mm, 3 mm and 5 mm below the applicator-tissue contact area.
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Table 3 Transmural temperatures in-vitro [7] vs. in-silico after 300 s freezing
Distance (mm) In-vitro (°C) [7] In-silico (°C)
1 -54.5 ± 4.1 -55.3
2 -40.7 ± 7.2 -37.9
3 -31.5 ± 7.0 -26.1
5 -16.8 ± 4.9 -11.5
boundary conditions at the blood and tissue boundaries a and b (the heat transfer coeffi-
cient α was reduced from 1500Wm−2 °C−1 to 700Wm−2 °C−1 to consider water at rest
and the external temperature Tc was set to 37°C).
Temperatures were extracted 1 mm, 2 mm, 3 mm and 5 mm beneath the applicator and
compared with the measurements ofWood et al. [7] simplified as fitted monoexponential
functions in their work (see Figure 10). Transmural temperatures in-vitro [7] vs. in-silico
after 300 s freezing are in a similar range (see Figure 10 and Table 3).
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